Connection

Daniel Steinberg to Angioplasty, Balloon, Coronary

Back to Details
This is a "connection" page, showing publications Daniel Steinberg has written about Angioplasty, Balloon, Coronary.
Daniel Steinberg
Connection Strength
3.856
Angioplasty, Balloon, Coronary
  1. Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
    View in: PubMed
    Score: 0.384
  2. Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital. Am J Cardiol. 2012 Apr 15; 109(8):1154-9.
    View in: PubMed
    Score: 0.372
  3. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
    View in: PubMed
    Score: 0.330
  4. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
    View in: PubMed
    Score: 0.304
  5. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol. 2008 Jul 15; 102(2):160-4.
    View in: PubMed
    Score: 0.289
  6. Snare extraction of a fractured coronary stent in a saphenous vein graft. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):241-3.
    View in: PubMed
    Score: 0.273
  7. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J. 2010 May; 31(9):1079-87.
    View in: PubMed
    Score: 0.081
  8. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):156-61.
    View in: PubMed
    Score: 0.078
  9. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):866-70.
    View in: PubMed
    Score: 0.078
  10. Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol. 2009 May; 21(5):210-4.
    View in: PubMed
    Score: 0.077
  11. Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era. Am J Cardiol. 2009 Apr 01; 103(7):950-3.
    View in: PubMed
    Score: 0.077
  12. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
    View in: PubMed
    Score: 0.076
  13. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Am J Cardiol. 2009 Feb 15; 103(4):496-500.
    View in: PubMed
    Score: 0.076
  14. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
    View in: PubMed
    Score: 0.076
  15. Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
    View in: PubMed
    Score: 0.076
  16. Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009 Mar 01; 103(5):653-8.
    View in: PubMed
    Score: 0.076
  17. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):799-803.
    View in: PubMed
    Score: 0.075
  18. Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Nov 15; 102(10):1318-22.
    View in: PubMed
    Score: 0.074
  19. Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions. Am J Cardiol. 2008 Nov 01; 102(9):1175-81.
    View in: PubMed
    Score: 0.074
  20. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
    View in: PubMed
    Score: 0.072
  21. Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. Am J Cardiol. 2008 Aug 01; 102(3):287-91.
    View in: PubMed
    Score: 0.072
  22. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008 Jun 01; 101(11):1544-9.
    View in: PubMed
    Score: 0.072
  23. Drug-eluting stent thrombosis. Minerva Cardioangiol. 2008 Feb; 56(1):127-37.
    View in: PubMed
    Score: 0.071
  24. Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol. 2008 Feb 15; 101(4):452-6.
    View in: PubMed
    Score: 0.070
  25. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
    View in: PubMed
    Score: 0.070
  26. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Feb 01; 101(3):293-9.
    View in: PubMed
    Score: 0.070
  27. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007 Sep 11; 116(11 Suppl):I200-6.
    View in: PubMed
    Score: 0.069
  28. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):167-72.
    View in: PubMed
    Score: 0.068
  29. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol. 2007 Sep 15; 100(6):965-9.
    View in: PubMed
    Score: 0.068
  30. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
    View in: PubMed
    Score: 0.068
  31. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007 Mar 01; 99(5):599-602.
    View in: PubMed
    Score: 0.066
  32. Can acute occlusion of the left anterior descending coronary artery produce a typical "takotsubo" left ventricular contraction pattern? Am J Cardiol. 2009 Jul 15; 104(2):202-4.
    View in: PubMed
    Score: 0.019
  33. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
    View in: PubMed
    Score: 0.019
  34. Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events. J Invasive Cardiol. 2008 Dec; 20(12):635-9.
    View in: PubMed
    Score: 0.019
  35. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol. 2008 Dec 15; 102(12):1614-7.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.